Friday 08 March 2024 | 22:20 US FDA delays Lilly Alzheimer’s drug decision, calls for advisory panel The U.S. Food and Drug Administration has delayed its decision on Eli Lilly’s LLY.N experimental treatment for early Alzheimer’s disease and will hold a meeting of ... By Reuters News Service
